Background: Nitrogen dioxide (NO 2 ) is a toxic byproduct of inhalation therapy with nitric oxide (NO). The rate of NO 2 formation during NO therapy is controversial. Methods: The formation of NO 2 was studied under dynamic flows emulating a base case NO ventilator mixture containing 80 ppm NO in a 90% oxygen matrix. The difficulty in measuring NO 2 concentrations below 2 ppm accurately was overcome by the use of tunable diode laser absorption spectroscopy. Results: Using a second-order model, the rate constant, k, for NO 2 formation was determined to be (1.19 ؎ 0.11) ؋ 10 ؊11 ppm ؊2 s ؊1 , which is in basic agreement with evaluated data from atmospheric literature. Conclusions: Inhaled NO can be delivered safely in a well-designed, continuous flow neonatal ventilatory circuit, and NO 2 formation can be calculated reliably using the rate constant and circuit dwell time. 6 Nonstandard abbreviations: ppm, parts per million; TDLAS, tunable diode laser absorption spectroscopy; and MFC, mass flow controller.
Inhaled nitric oxide (NO) is being evaluated under numerous investigational new drug applications for the treatment of diseases ranging from adult respiratory distress syndrome to persistent pulmonary hypertension of the newborn. The gas concentration unit selected for this evaluation is parts per million (ppm), 6 which is defined as the amount of substance fraction in micromoles per mole (mol/mol). Trace amounts of NO (0.1-80 ppm) are mixed with the inspiratory gases of ventilatory assis-tance devices and delivered via inhalation with the intent of reducing pulmonary vascular resistance, enhancing ventilation-perfusion matching, and improving oxygenation. Although NO is a toxic gas at concentrations Ͼ200 ppm, the currently administered concentrations of Յ80 ppm appear to be without direct toxic effects when inhaled for short periods of time (1) (2) (3) (4) (5) (6) (7) .
When NO is mixed with oxygen in a gaseous environment, nitrogen dioxide (NO 2 ) is formed spontaneously by a termolecular mechanism (8 ) . The chemical reaction is described in Eq. 1:
The rate expression for the formation of NO 2 is given by Eq. 2, which shows this reaction to have first-order dependence on oxygen concentration and second-order dependence on NO concentration:
NO 2 is a toxic gas, and the Occupational Safety and Health Administration limits human peak exposure to 5 ppm (9 ) . However, alterations of airway reactivity have been reported in humans at exposures as low as 1.5 ppm (10 ) . Concern has focused on delivering inhaled NO in a high oxygen concentration environment. The amount of NO 2 formed spontaneously and subsequently inspired by the patient is of prime importance. Several investigators reported their experience regarding NO 2 formation during inhaled NO delivery (11) (12) (13) (14) (15) (16) . The rates of formation of NO 2 were calculated or measured, but varied appreciably between reports. A secondary issue is the ability of presently available analyzer systems to measure NO 2 accurately in this environment (15, 17 ) .
The goal of this study was to examine the rate of NO 2 formation under clinical conditions in a continuous flow neonatal ventilator circuit. The measurement of NO 2 was accomplished by the use of a tunable diode laser absorp-tion spectrometer (TDLAS), which permitted the accurate measurement of NO 2 without interference from components of the inhaled NO ventilator matrix.
Materials and Methods neonatal ventilator circuit
A conventional mechanical ventilator (model IV-100B; Sechrist), a respiratory humidifier (Fisher & Paykel Healthcare), and a capped custom isothermal infant respiratory breathing circuit (model 7411-4S2; Baxter) were assembled in the usual fashion. 7 The oxygen flowmeter was replaced with a digital mass flowmeter (Tylan Corp.). NO was introduced at the temperature probe port, proximal to the endotracheal tube adapter ( Fig. 1 , circuit A, site A). Gas was sampled for analysis by the TDLAS vacuum inlet immediately proximal to the endotracheal tube adapter ( Fig. 1 , circuit A, site B). The volume of the circuit through which the inspired gas mixture flowed after NO and oxygen were mixed and which ended at the patient (inlet of TDLAS) was 0.193 Ϯ 0.005 L. The elapsed time for the NO in oxygen mixture to reach the TDLAS is the system dwell time. The ventilator was used to study NO 2 formation for dwell times between 1.37 and 5.57 s.
laboratory gas mixing circuit
To measure NO 2 formation at longer dwell times, a special Pyrex dual chamber gas mixing apparatus was used to provide a circuit volume of 0.653 Ϯ 0.003 L ( Fig.  1, circuit B ). The mixing apparatus was used to study NO 2 formation for dwell times between 3.9 and 13 s.
Experiments were conducted at ambient conditions with a room temperature of 21.0 Ϯ 0.5°C at a circuit pressure of 0.101 Ϯ 0.002 MPa (1 atmosphere). Twentytwo experiments covering 13 dwell times were conducted over a 3-day period, with 7 dwell time conditions being repeated on different days. NIST gaseous Standard Reference Material 2735, which is certified to contain 793.5 Ϯ 4.0 ppm NO and 1.9 Ϯ 0.2 ppm NO 2 , was used as the NO source gas. For each experiment, Standard Reference Material 2735 was dynamically diluted 1:9 with 99.6% purity oxygen, using calibrated mass flow controllers (MFCs) to give NO concentrations between 79 and 81 ppm. The total gas flow rate was varied between 3 and 10 L/min through the ventilator circuit or the special mixing apparatus to achieve 13 dwell times to investigate NO 2 formation. The mass flows were allowed to equilibrate for a minimum of 5 min, after which the amount of NO being delivered was verified by use of a chemiluminescence monitor (CLD 700 AL; Eco Physics). The NO 2 concentration was determined from the ratio of an integrated NO 2 TDLAS absorbance line profile calibrated against a NIST gas standard. The TDLAS 30-L gas cell contained 72 kPa-L of sample under dynamic flow at approximately 52 kPa-L per minute. This translates to an average dwell time in the TDLAS cell of 1.4 min, during which some NO 2 will form even at the greatly reduced pressure of 2.4 kPa. The total cell background for the experiments each day was estimated by a linear regression plot of the inverse of the total circuit flow rate (x values) vs the measured TDLAS NO 2 output (y values). The y-intercept of the linear plot represented the total NO 2 background as the circuit flow rate approaches infinity (x ϭ 0). The cell contribution to the total background value was estimated by subtracting the NO 2 impurity of the diluted NO source mixture (Standard Reference Material 2735) from the total intercept value.
gas flow measurement
The MFCs (Model FC260; Tylan Corp.) were calibrated with a volumetric gas flow calibrator (Califlow A-100; MKS Instruments) for the NO source mixture and the dilution oxygen. The equation for the mass flow calibration line for each flowmeter was used to predict the MFC readings necessary to produce 1:9 dilution ratios for total flows of 3-10 L/min.
tdlas set-up
The NIST TDLAS system has been described in detail previously (18 ) . Briefly, the sample gas is flowed continuously through a White-type gas cell estimated to have a volume of 30 L. The inlet flow rate at the cell is adjusted as necessary to maintain a cell pressure of 2.40 Ϯ 0.07 kPa (18 Torr) . The inlet flow rate is estimated to be ϳ0.5 L/min. The cell pressure is monitored by a calibrated capacitance manometer. The path length of the multipass cell was set to 81.59 m. A lead salt diode laser (Laser 7 Identification of commercial equipment in this article is to provide as complete a description of the experimental procedures followed as possible. Such identification does not constitute a recommendation or endorsement by NIST of the vendor or equipment. Photonics) with a tuning range centered around 2940 cm Ϫ1 was set to scan over a single ro-vibrational transition of the NO 2 1 ϩ 3 band (19 ) . The narrow tuning range of the laser minimized any interference from species such as water in the system. The second-derivative absorbance signal was monitored by modulating the frequency of the diode laser at 36.3 KHz and processing the signal with a high-speed lock-in amplifier.
The line strengths for the NO 2 transitions in the 2940 cm Ϫ1 region are on the order of 1 ϫ 10 Ϫ23 cm Ϫ1 /(molecules/cm 2 ) (20 ) . For the experimental conditions described above, the absorbances [ln(I o /I)] are approximately 0.005 or less, where I o and I are the incident and transmitted intensities. At this absorbance, the sample is optically thin, and the peak-to-peak second harmonic signal at the line center varies linearly as a function of the NO 2 concentration and is given by the product:
where L is the path length, P is the sample pressure, ␣ is the absorption coefficient at line center, and H 2 accounts for the modulation effects (21 ) . The NO 2 concentration was obtained by comparing the signal strength to the signal obtained from a NIST gas standard containing 4.5 Ϯ 0.2 ppm NO 2 in nitrogen. Table 3 ). This value agrees within Ϯ 20% with the measured k above, falling within their respective measurement uncertainties. The data presented here show that in all likelihood the kinetics of NO 2 formation are the same whether describing inhaled NO therapy or atmospheric smog reactions. For example, at the clinically important conditions of 80 ppm NO in a 90% oxygen matrix, Eq. 4 gives: Thus, NO 2 is predicted to form at a rate of ϳ0.14 ppm per second of dwell time for 80 ppm NO in a 90% oxygen matrix. Fig. 2 is a plot of 13 measured data points taken from Table 1 , which shows the linear dependence of the NO 2 formed as a function of dwell time.
Results
d͓NO 2 ͔/dt ϭ ͓2.38 ϫ 10 Ϫ 11 ppm Ϫ 2 s Ϫ 1 ͔ ͓80 ppm͔ 2 ͓9.0 ϫ 10 5 ppm͔(5)
discussion of uncertainty
The estimates of measurement uncertainty are reported as expanded values (2 ), using U ϭ kU %RSD , where the expansion factor k ϭ 2 and U %RSD is the uncertainty in a measurement expressed as a percentage of relative SD. The expanded uncertainty in the NO concentration estimated from the mass flow measurements is 2%. The uncertainty in the system dwell time is 3%. The measurement of NO 2 on the TDLAS is limited by ambient variations in the cell temperature (0.4%), variations in the cell pressure (3%), and the TDLAS absorbance integration imprecision (2%). The uncertainty because of systematic effects in the NO 2 reference standard (4.4%) is combined with the random uncertainty. The overall uncertainty in the measured rate constant is given by: (7) or U K ϭ 4.4% ϩ ͓͑2%͒ 2 ϩ ͑3%͒ 2 ϩ ͑0.4%͒ 2 ϩ ͑3%) 2 ϩ (2%) 2 ] 0.5 ϭ 9.5% (8) As discussed above, the imprecision from 13 measured values of the rate constant shown in Table 1 is 2.7%RSD, which when expanded by the appropriate t-value for the 95% confidence interval (t ϭ 2.2) is equal to 5.9% (2 ) . This value is consistent with the Ϯ 5.1% value calculated under quadrature in Eq. 8. The relative expanded uncertainty, U K , in the rate constant is Ϯ 9.5% relative, and the rate constant is expected to lie within Ϯ U K with a level of confidence close to 95% (23 ) .
no 2 formation dependence on no concentration
Additional experiments were carried out to demonstrate the second-order dependence of the rate of formation of NO 2 on the NO concentration. Table 2 shows the NO 2 concentration measured by TDLAS for NO values ranging from 10 to 100 ppm at a constant dwell time of 3.91 s. The measured NO 2 concentrations are compared in Table 2 with calculated values for NO 2 formation predicted using Eq. 4 and the "preferred equation" from Atkinson et al. (22 ) .
Discussion
In 1974, the International Council of Scientific Unions through its Committee on Data for Science and Technology (CODATA) published CODATA Bulletin 13 titled "The Presentation of Chemical Kinetics Data in the Primary Literature" (24 ) . Much of the kinetics data published since 1974 has followed this format to have relevance with other kinetic data measured throughout the global scientific community. The current study adheres to these recommendations and demonstrates that only one rate equation (Eq. 2) and one rate constant is needed to model NO 2 formation in a patient delivery circuit under a broad range of test conditions. The rate constant k was measured here to be 1.19 Ϯ 0.11 ϫ 10 Ϫ11 ppm Ϫ2 s Ϫ1 and was reasonably estimated (Ϯ 20%) from the evaluated rate constant given by Atkinson et al. (22 ) , adjusted for 101 kPa (1 atmosphere) and 21°C (see Table 3 ).
Some clinical studies have raised confusion when describing measured NO 2 formation using other formats, including reaction models, kinetic rate expressions, and rate constants. One example, Nishimura et al. (16 ) , pro- vided a comprehensive study that investigated NO 2 formation during a simulation of inhaled NO therapy in adults. Nishimura et al. used an integrated form of Eq. 9, published by Glasson and Tuesday (25 ) in 1963:
Although Nishimura et al. (16 ) and this study are in basic agreement on the concentrations of NO 2 formed from similar experiments, their reported rate constants are a factor of 2 greater than those reported by Atkinson et al. (22 ) and this study. Much of the "confusion" can be eliminated by presenting results in a common format and by using reasonable estimates of ventilator circuit dwell times.
The clinical environment of 80 ppm NO in a 90% oxygen matrix was selected for investigation because it represents the high end of NO concentrations under use in clinical trials, and therefore the maximum rate of NO 2 formation likely to be encountered. When NO is being delivered in this environment, NO 2 formation is ϳ0.14 ppm/s. The recommended ventilator circuit that adds the NO source gas as close to the patient as practical ( Fig. 1 , circuit A, site A) will have a small system volume (Ͻ0.1 L). The use of recommended total flow rates exceeding 10 L/min (0.167 L/s) will limit the dwell time to Ͻ0.6 s. When Eq. 6 is used, the maximum NO 2 formed will be 0.08 ppm. It has been verified in this study that when delivering ventilator gases with NO concentrationsϽ80 ppm, the rate of NO 2 formation will decrease as a function of the square of the NO concentration. This dramatic lowering of NO 2 formation is predicted by Eq. 4 and demonstrated by measured data presented in Table 2 .
effect of humidity
Although the majority of the measurements were performed in a dry circuit at 21°C, two experiments were performed using the Sechrist ventilator where humidity was added to the dilution oxygen. The addition of the hot saturated water vapor heated the gas in the ventilator circuit to 36°C. The observed concentration of NO 2 formed (TDLAS) was observed to be ϳ20% lower in the humidified gas. This decrease is consistent with the termolecular mechanism (Eq. 1) where NO 2 production has previously been observed to decrease continuously with increasing temperature until a minimum is reached at 327°C (8 ) . Thus, the observed effect on the NO 2 production after humidity was added to the circuit was consistent with the expected rate decrease predicted by the higher temperature of the gas in the delivery circuit.
other no 2 sources
This investigation resolves the question of NO 2 formation within a continuous flow delivery circuit. However, there are additional sources of NO 2 that can be delivered to the patient. The NO source cylinder always contains a small concentration of NO 2 , which will lead to the delivery of some NO 2 to the patient. For example, an 800-ppm NO source cylinder often contains 8 ppm NO 2 , which is only 1% contamination relative to the NO concentration. This source gas is then diluted 1:9 to achieve a ventilator mixture containing 80 ppm NO and 0.8 ppm NO 2 that is being delivered to the patient. In this example, there is 10-fold more NO 2 in the circuit from the source cylinder than is formed spontaneously in the circuit. On the basis of this analysis, it is important that NO source mixture manufacturers focus on production practices that minimize the amount of NO 2 in the source cylinders.
It is possible to accidentally contaminate NO source cylinders with NO 2 formed via a back diffusion mechanism when the cylinder valve is opened to an improperly purged regulator containing trace amounts of room air. Vacuum purging of regulators to remove ambient air before opening the cylinder valve can minimize any potential for accidental contamination of the cylinder. The importance of accidental contamination is difficult to evaluate. However, until data are available, the appropriate purging and handling of NO cylinders is recommended.
Whenever NO is in the presence of oxygen, additional NO 2 production can occur. The dwell time within the conductive airways will add to the amount of NO 2 delivered to the patient. Additional areas of concern yet to be investigated include the production of NO 2 at the alveolus.
In summary, NO 2 formation is minimal during inhaled NO therapy in the continuous flow neonatal ventilatory circuit described in Fig. 1 , circuit A. Existing chemical kinetics and rate constants can be used to reliably predict the amount of NO 2 formed in a continuous flow system. At fixed NO and oxygen concentrations, the amount of NO 2 formed will be dependent upon the dwell time. Table 3 . Comparison of measured rate constant k for NO 2 formation for present study and Atkinson et al. (22) in various units.
Base unit of concentration
Measured rate constant, k Investigators using inhaled NO therapy should calculate dwell times and the potential NO 2 delivery to the patient. Additional sources of NO 2 (NO source cylinder, cylinder contamination, NO 2 formation within the conductive airways and at the alveolus) need to be considered when estimating the total NO 2 delivery to the patient.
